🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, randomized, double-blind, active-controlled study aims to...
Status
Active Not Recruiting
Location
Dermatology Hospital of Shandong First Medical University (Shandong Provincial Hospitial of Dermatology)
Start Date
2025-05-27
Trial ID
NCT06945107
Treatments Being Tested
The purpose of this study is to assess efficacy safety and tolerability of ...
Status
Recruiting
Location
Dermatology Hospital affiliated to Shandong First Medical University
Start Date
2025-03-19
Trial ID
NCT06895499
The purpose of this study is to assess efficacy, safety, pharmacokinetics a...
Status
Recruiting
Location
Ondokuz Mayis University Medical Faculty
Start Date
2025-12-16
Trial ID
NCT07244510
Treatments Being Tested
The purpose of this research study is to evaluate the effectiveness and saf...
Status
Completed
Location
Windsor Dermatology - Psoriasis Treatment Center of Central New Jersey
Start Date
2024-06-03
Trial ID
NCT06336343
Treatments Being Tested
JS005-002 is a randomized, double-blinded, placebo-controlled phase Ib/II c...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2021-01-20
Trial ID
NCT05344248
Treatments Being Tested
This study is a multicenter, randomized, double-blind, parallel-arm, Phase ...
Status
Completed
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2022-10-26
Trial ID
NCT05377944
Treatments Being Tested
The purpose of this study is to assess efficacy safety and tolerability of ...
Status
Not Yet Recruiting
Location
Dermatology Hospital affiliated to Shandong First Medical University,
Start Date
2026-03-27
Trial ID
NCT07449156
The purpose of this study is to demonstrate the efficacy and safety of secu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-10-03
Trial ID
NCT02721966
Treatments Being Tested
A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Dose-Ranging, ...
Status
Terminated
Location
Zai Lab Site 5013
Start Date
2024-05-22
Trial ID
NCT06380907
This is an open label, phase 1, "3+3" dose escalating study of tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2015-03
Trial ID
NCT02380287
Treatments Being Tested